BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35456457)

  • 1. Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.
    Huang X; Rehman HM; Szöllősi AG; Zhou S
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
    Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
    Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
    Zhou X; Tan F; Zhang S; Wang A; Zhang T
    Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology.
    Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T
    J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
    Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
    Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active ingredients and molecular targets of
    Zheng Y; Ji S; Li X; Feng Q
    PeerJ; 2022; 10():e13737. PubMed ID: 35873910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
    Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
    Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology.
    Jiang J; Yang Z; Hou G; Yao X; Jiang J
    Ann Hepatol; 2022; 27(4):100701. PubMed ID: 35351639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis.
    Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C
    J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of
    Khan SA; Lee TKW
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
    Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.
    Liu P; Han B; Zhang Y; Wang X
    Comput Intell Neurosci; 2022; 2022():7102500. PubMed ID: 35720901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on molecular mechanism of Solanum nigrum in treatment of hepatocarcinoma based on network pharmacology and molecular docking].
    Liu JH; Lyu DY; Zhou HM; Kuang WH; Chen ZX; Zhang SJ
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):163-168. PubMed ID: 32237426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network pharmacology integrated serum pharmacochemistry strategy for uncovering efficacy of YXC on hepatocellular carcinoma.
    Zhou TT; Zhu WJ; Feng H; Ni Y; Li ZW; Sun DD; Li L; Tan JN; Yu CT; Shen WX; Cheng HB
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117125. PubMed ID: 37699493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
    Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
    Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
    Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
    Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
    Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
    J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.